KalVista Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2017 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending July 31, 2024 was $37.2M, a 89.5% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$84.7M, a 305% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $41.4M, a 28.4% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $57.9M.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $37.2M +$17.5M +89.5% May 1, 2024 Jul 31, 2024 10-Q 2024-09-05
Q2 2023 $19.6M -$10.4M -34.7% May 1, 2023 Jul 31, 2023 10-Q 2024-09-05
Q2 2022 $30M +$15.2M +102% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q2 2021 $14.9M +$9.37M +170% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q2 2020 $5.51M +$7.04M May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q2 2019 -$1.53M -$965K -171% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q2 2018 -$565K -$455K -414% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q2 2017 -$110K May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.